Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Veziris

Showing results (11-20 of 114) with videos related to

Pageof 12
Sort By:
Presse Medicale (Paris, France : 1983)|November 7, 2006
[Trends in tuberculosis treatment duration]Nicolas Veziris, Alexandra Aubry, Chantal Truffot-Pernot
Infectious Diseases Now|October 15, 2023
Optimizing the use of current antituberculosis drugs to overcome drug resistance in Mycobacterium tuberculosisThomas Maitre, Alain Baulard, Alexandra Aubry, et al.
Antimicrobial Agents and Chemotherapy|March 16, 2011
Activity of carbapenems combined with clavulanate against murine tuberculosisNicolas Veziris, Chantal Truffot, Jean-Luc Mainardi, et al.
The Journal of Antimicrobial Chemotherapy|March 25, 2016
Rifabutin: where do we stand in 2016?Yoann Crabol, Emilie Catherinot, Nicolas Veziris, et al.
Plos One|March 17, 2011
Sterilizing activity of second-line regimens containing TMC207 in a murine model of tuberculosisNicolas Veziris, Murad Ibrahim, Nacer Lounis, et al.
Plos Neglected Tropical Diseases|October 19, 2016
Sterilizing Activity of Fully Oral Intermittent Regimens against Mycobacterium Ulcerans Infection in MiceAurélie Chauffour, Jérôme Robert, Nicolas Veziris, et al.
Plos Neglected Tropical Diseases|May 8, 2025
Unprecedented in vivo activity of telacebec against Mycobacterium lepraeAurélie Chauffour, Emmanuelle Cambau, Kevin Pethe, et al.
Journal of Medical Microbiology|September 12, 2009
Daptomycin is not active against rapidly growing mycobacteriaSylvaine Bastian, Florence Brossier, Claudine Wichlacz, et al.
Journal of Clinical Microbiology|March 26, 2010
Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolatesFlorence Brossier, Nicolas Veziris, Alexandra Aubry, et al.
La Revue Du Praticien|March 29, 2024
[Advances in antibiotic therapy for tuberculosis]Thomas Maitre, Lorenzo Guglielmetti, Jérôme Robert, et al.
Pageof 12

Showing results (11-20 of 114) with videos related to

Sort By:
Pageof 12
Presse Medicale (Paris, France : 1983)|November 7, 2006
[Trends in tuberculosis treatment duration]Nicolas Veziris, Alexandra Aubry, Chantal Truffot-Pernot
Infectious Diseases Now|October 15, 2023
Optimizing the use of current antituberculosis drugs to overcome drug resistance in Mycobacterium tuberculosisThomas Maitre, Alain Baulard, Alexandra Aubry, et al.
Antimicrobial Agents and Chemotherapy|March 16, 2011
Activity of carbapenems combined with clavulanate against murine tuberculosisNicolas Veziris, Chantal Truffot, Jean-Luc Mainardi, et al.
The Journal of Antimicrobial Chemotherapy|March 25, 2016
Rifabutin: where do we stand in 2016?Yoann Crabol, Emilie Catherinot, Nicolas Veziris, et al.
Plos One|March 17, 2011
Sterilizing activity of second-line regimens containing TMC207 in a murine model of tuberculosisNicolas Veziris, Murad Ibrahim, Nacer Lounis, et al.
Plos Neglected Tropical Diseases|October 19, 2016
Sterilizing Activity of Fully Oral Intermittent Regimens against Mycobacterium Ulcerans Infection in MiceAurélie Chauffour, Jérôme Robert, Nicolas Veziris, et al.
Plos Neglected Tropical Diseases|May 8, 2025
Unprecedented in vivo activity of telacebec against Mycobacterium lepraeAurélie Chauffour, Emmanuelle Cambau, Kevin Pethe, et al.
Journal of Medical Microbiology|September 12, 2009
Daptomycin is not active against rapidly growing mycobacteriaSylvaine Bastian, Florence Brossier, Claudine Wichlacz, et al.
Journal of Clinical Microbiology|March 26, 2010
Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolatesFlorence Brossier, Nicolas Veziris, Alexandra Aubry, et al.
La Revue Du Praticien|March 29, 2024
[Advances in antibiotic therapy for tuberculosis]Thomas Maitre, Lorenzo Guglielmetti, Jérôme Robert, et al.
Pageof 12